Seattle, WA Regional Conference
June 8, 2018
Seattle, WA
CEU Application | Conference Brochure
Cybersecurity
Kevin Brennan, Special Agent, FBI
- Current Cyber Threats - What threats to all internet connected organizations face?
- “Emerging” Cyber Threats - What are the emerging threats to internet connected organizations?
- Healthcare Specific Cyber Threats - What threats to healthcare organizations face?
No presentation available
Prescription Monitoring Program: Is Your Organization Compliant?
Blake Maresh, Executive Director, Health Systems Quality Assurance, WA Dept. of Health
- An overview of the basics of the Washington PMP.
- The role the PMP can play in reducing the misuse and abuse of opioids.
- An overview of recent changes in law and rule related to opioid prescribing, including PMP use.
- The development and use of PMP provider feedback reports and expanded access to PMP data.
Presentation (2 slides/page)
Presentation (3 slides/page)
OIG Update & Compliance with the Anti-Kickback Statute
Steven Ryan, Special Agent, OIG
Katherine Matos, Senior Counsel, HHS/OIG/OCIG
- Foundations of the anti-kickback statute (AKS)
- AKS Enforcement and Compliance
- Other Updates
No presentation available
Corruption, SOX, Stark/AKS
Larissa Payne, Director for the Medicaid Fraud Control Unit in the Office of the Washington State Attorney General’s Office
- Corruption – strawmen/ straw companies, good for scarecrows, bad for business
- Back kicks are fine, kickbacks are not. Examples of kickback schemes – i.e. when to call Medicaid Fraud
- SOX and fraud. Why the internal controls, ethics and disclosures matter to fraud investigations
Presentation (2 slides/page)
Presentation (3 slides/page)
Implementing an Effective Drug Diversion Compliance Program
Rick Quintero, Drug Diversion Program Manager, DEA
- Discuss ways that prescription controlled substances are being diverted from the pharmaceutical supply chain.
- Identify areas where U.S. Drug Enforcement Administration, local law enforcement, and medical professionals can work together to curb prescription drug abuse.
- Describe common “red flags” that DEA Registrants should recognize regarding errant prescribing, forgeries, and recipient drug-seeking behavior.
No presentation available
HIPAA Privacy – Case Studies: How to Protect Your Organization
Lesley Morgan, JD, Investigator, OCR
- Privacy Rule Overview
- Security Rule Overview
- Breach Notification Rules Overview
- Updates and Enforcement Actions
What’s On the Horizon for Compliance Professionals
Moderator:
Robert Homchick, Partner, Davis Wright Tremaine, LLP
Panel:
Phil Hurd, Director, Berkeley Research Group, LLC
Lori Laubach, Director, Moss Adams, LLP
Karolyn Woo-Miles, Partner, Deloitte & Touche
- Hot Compliance Issues for 2018
- How has the 60 Day Rule changed the risk calculus?
- New Compliance issues in a Value Based World
- How to Identify Program Priorities?
No presentation available
No